Table 1.
MMN (n = 10) | ALS (n = 10) | Healthy controls (n = 10) | |
---|---|---|---|
Mean age, years (range) | 54 (29–67) | 53 (40–60) | 54 (29–67) |
Male (%) | 8 (80 %) | 8 (80 %) | 8 (80 %) |
Median duration of symptoms in months (range) | 52 (11–124)* | 11 (6–34)* | – |
Median duration of treatment in months (range) | 12 (1–39) | 4 (1–24) | – |
Weakness lower arm (%) | 15/20 (75 %) | 15/20 (75 %) | – |
Number of conduction blocks (%) | 7 (18 %) | 0 (0 %) | 0 (0 %) |
Number of nerves with distal compound muscle action potential < lower limit of normal (%) | 6 (15 %) | 8 (20 %) | 0 (0 %) |
*P < 0.001